Organo (6368) Q2 2026 earnings summary

Executive summary

• Orders received and net sales for the first half of FY ending March 2026 grew significantly year-on-year, driven by large-scale overseas semiconductor projects, especially in Taiwan, the US, and Europe, and robust demand for AI-related semiconductors and maintenance services.

• Operating profit and profit attributable to owners of parent increased sharply year-on-year, with profit margin improvements in Plant projects offsetting higher SG&A expenses.

• The order backlog as of September 30, 2025, was ¥124,073 million, down 9.9% year-on-year.

Financial highlights

• First-half orders received: ¥100.3 billion, up 8.1% year-on-year; net sales: ¥82.8 billion, up 11.4% year-on-year.

• Operating profit for the first half: ¥17.4 billion, up 51.4% year-on-year; profit margin rose to 21.0%.

• Profit attributable to owners of parent: ¥11.5 billion, up 41.7% year-on-year; basic earnings per share: ¥250.78.

• Ordinary profit: ¥17,349 million, up 45.2% year-on-year.

• Gross margin improved to 36.4% in the first half, up 5.3 points year-on-year.

Outlook and guidance

• Full-year orders received forecast: ¥185.0 billion, up 22.3% year-on-year; net sales forecast: ¥175.0 billion, up 7.2%.

• Full-year operating profit forecast: ¥36.0 billion, up 15.7% year-on-year; profit attributable to owners of parent forecast: ¥27.0 billion, up 11.8%; basic earnings per share forecast: ¥587.32.

• Dividend forecast for FY03/2026 raised to ¥190 per share, maintaining a payout ratio above 30%.